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Summary.-The topical carcinogenicity to mouse skin of smoke condensates ob-
tained from a tobacco substitute (NSM), alone or in combination with tobacco, has
been compared with condensate from tobacco and with acetone, the solvent used.
Sixteen different types of cigarette were used to make the condensates, and the age-
standardized results have been analysed according to the Weibull distribution model.
The results show that NSM condensate has less than 25% of the potency of tobacco
condensate (37 0 at 95 0 upper confidence limit), and that condensates from blends of
NSM and tobacco are similarly reduced in activity. General pathology analysis
failed to reveal abnormalities due to NSM.
THE chemical complexity of cigarette
smoke precludes the precise attribution of
the known carcinogenic effects to a single
component or group of components, and
animal models are therefore required to
assay carcinogenic activity. A model
commonly used is the topical application
of smoke condensates to mouse skin, and
measurement of the incidence of tumours
which result. The method has been much
used to monitor attempts at reduction of
the carcinogenicity of tobacco smoke, and
although there is as yet no evidence
equating mouse skin response with the
human lung response, it is assumed that a
direct relationship exists between the
ability to induce tumours in mouse skin
and in the human bronchial tract.
The experiments described were de-
signed to determine the carcinogenic
potential of smoke condensate from a
substitute smoking material and from
blends of this material with conventional
tobacco.
MATERIAL AND METHODS
Cigarette8.-These were 2 sizes, each 70
mm long, but either 23-0 or 25-4 mm in
circumference (designated A and B respec-
tively). The cigarettes were either unfiltered
or filtered with a 15 mm crimped paper/
acetate fibre filter showing 35% nicotine
retention. The tobacco used was a com-
mercial blend of flue-cured tobaccos, but
contained no crushed stem (Imperial Tobacco
Ltd, Bristol).
The substitute was NSM (New Smoking
Materials Ltd, Wilmslow) of the following
composition:
Heat-treated cellulose
Sodium carboxy methyl cellulose
Glycerol
Calcium carbonate
Magnesium carbonate
Bentonite
Ammonium sulphate
26a9%
15.Ooo
6*0%
16.5%
28*6%o
5*00
2*0%
Four different materials were used to
prepare condensate:
(1) 100% tobacco
(2) 800% tobacco blended
(80/20 blend)
(3) 5500 tobacco blended
(55/45 blend)
(4) 100% NSM.
with 20% NSM
with 45% NSM
Condensate preparation.-Cigarettes were
smoked on a rotary smoking machine (R. W.
Mason, Moor Lane, Clevedon, Bristol) similarM. J. L. CLAPE, D. M. CONNING AND J. WILSON
to that described by Day (1967). The
smoking machine operated by connecting in
turn each of 24 cigarettes, which were
secured inholders situated around arevolving
disc, to a vacuum source. The unlighted
end of each cigarette was open to the atmo-
spherebetweenpuffs. Cigaretteswerelighted
by an .qlectrically heated coil, and replaced
when individual cigarettes had reached an
estimated butt length of20 mm. The smok-
ing constants used were a conventional puff
volume of 35 ml, puff duration of 2 s, and an
interval of 1 min (Rothwell and Grant, 1974).
Smoke was condensed using a cold impaction
trap, and the resultant tar suspended in
acetone:water (90: 10 v/v)mixture. Theyields
of condensate were expressed in terms of mg
of fresh anhydrous smoke (FAS) (Table I).
An aliquot ofthe condensate from each batch
of cigarettes was evaporated under reduced
pressure on a water bath at 40°C until con-
stant weight was obtained, the residue was
returned to the main solution, which was then
dilutedwiththeappropriatevolume ofsolvent
togivethedesireddryweightperunitvolume.
The condensates were prepared at weekly
intervals and stored at room temperatures
until and during use. They were normally
between 2 and 3 weeks old when applied to
the miee, during which time it is known that
the tumour-producing effect of condensate is
virtually unchanged (Day, 1967).
The condensate preparations were applied
with an " ARH continuous pipetting unit "
(Arnold R. Horwell Ltd) through a stainless
steel cannula 4 cm long and 2 mm in diameter
at the rate of 0 3 cm3 per mouse on 3 days
(Monday, Wednesday and Friday) in each
week. The animals were not " habituated "
to the treatment before starting the experi-
ment. Different doses were achieved by
variation in concentration, a fixed volume
being applied to each animal.
Control animals were treated with equiva-
lent volumes of solvent only.
Animals.-The 4,080 mice used in these
experiments were 4-5-week-old-CFLP female
mice, a hysterectomy-derived strain of Swiss
origin (Carworth-Europe, Alconbury, Hunt-
ingdon).
The cages (28.5 x28 x 10 cm) were con-
structed at 19-gauge galvanized wire mesh on
3 sides and floor with a solid back, and were
suspended over collecting trays. Each rack
contained 80 cages, and atotal of16rackswas
used for these experiments, 8 racks being
housed in each of 2 rooms. The position of
each unit was varied within each room to
avoid environmental bias from ventilation,
light and temperature.
The mice were allocated to cages on
arrival, and then distributed amongst the
groups on the basis of total body weight per
cage, to give equal weight distribution within
the groups. They were maintained on
pasteurized mouse cubes (Oakes ofCongleton,
Cheshire) and water ad libitum. The animals
were kept in a barrier-maintained area
throughout the experiment and the animal
rooms maintained at a temperature of 720 ±
20F.
The start was staggered over 13 weeks
The experiment was divided to allow equal
proportions of each group on the various
treatments to commence in the same week.
Treatment commenced after 2 weeks' cage
acclimatization, when the mice were 6-7
weeks of age. During the second week of
TABLE I.-Fresh Anhydrous Smoke Condensate (FAS).
Yield/cigarette and Cigarettes requiredfor 1 g
FAS mg
Cigs/g
FAS mg
Cigs/g
FAS mg
Cigs/g
FAS mg
Cigs/g
FAS mg
cigs/g
100%
Tobacco
34 1
29
25 5
39
30 7
33
21 6
46
28
37
80%/ Tobacco/
20% NSM
30 6
33
23 8
42
30 8
32
19 8
51
26 3
40
55% Tobacco/
45% NSM
24 8
40
20 5
49
24-4
41
15 7
64
21*4
49
B Plain
B Filter
A Plain
A Filter
Average
100%
NSM
7 1
141
5.5
182
7 6
132
5.5
182
6 4
159
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acclimatization the mice were prepared for
the initial treatment by shaving the dorsum
from the base of the tail to the nape of the
neck, with an Oster A5 electric hair clipper
(size 40 blade); this was repeated weekly
throughout the study. Care was taken to
avoidlacerating the skin, especiallyiftumours
were present. A vacuum attachment over
the oscillating teeth of the clipper reduced
the dispersion of contaminated hair into the
room atmosphere. Very occasionally, the
hair required cleaning with acetone to remove
inspissated tars prior to clipping.
During the course of the experiment, all
data obtained were recorded on cards
(Copeland-Chatterson Company Ltd) so that
one cardrepresented thehistoryofone mouse.
Experimental des8in.-Preliminary studies
showed thatNSM condensate has less carcino-
genic activity than tobacco condensate, and
that relatively few animals are needed to
confirm this. A major objective, however,
TABLE II.-Treatment Groups
Treatment
100% Tobacco
100% Tobacco
100% Tobacco
80% Tob/200% NSM
80% Tob/2O% NSM
80% Tob/20% NSM
55% Tob/45% NSM
55% Tob/45% NSM
55% Tob/45% NSM
1004% NSM
100% NSM
100% NSM
FAS dose (mg/wk)
75
126
210
75
126
210
75
126
210
126
210
300
Solvent
Type of cigarette
B plain
B filter
A plain
A filter
B plain
B filter
A plain
A filter
B plain
B filter
A plain
A filter
B plain
B filter
A plain
A filter
B plain
B filter
A plain
A filter
B plain
B filter
A plain
A filter
B plain
B filter
A plain
A filter
B plain
B filter
A plain
A filter
B plain
B filter
A plain
A filter
B plain
B filter
A plain
A filter
B plain
B filter
A plain
A filter
B plain
B filter
A plain
A filter
No. of animals
per group
250
250
250
250
250
250
80
80
80
50
50
30
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was to demonstrate with high confidence that
no adverse interaction occurs betweentobacco
and NSM in blends, particularly the 80/20
blend. The numbers of animals vary from
group to group, depending on the confidence
to be achieved (Table II).
The criteria used were:
(1) To check that blends of tobacco and
NSM do not result in a condensate
with an increase in skin-tumour-
producing activity of 10% or more
(1-tail : cx = 5% : , = 10% test)
compared with tobacco.
(2) To look for a 25% interaction between
tobacco and NSM in skin-tumour-
producing activity (1-tail : a= 5%
B = 5% test).
(3) To check that the skin-tumour-
producing activity ofNSM condensate
is certainly less than 70% that of
tobacco, and probably less than 50%
(1-tail: of - 5% : = 5%h test).
The doses of condensate employed were
selected to provide as near to a linear dose
response as possible. The low skin-tumour-
producing potential of NSM condensate
necessitated larger dosage with this material.
Observations
Body weight.-Individual mice were
weighed initially, and then weekly during the
first 12 weeks, and thereafter at fortnightly
intervals until death.
Food consumption.-Food consumption
per cage of 10 mice was recorded weekly for
the first 12 weeks.
Clinical observations.-All animals were
checked daily, and any abnormality in
behaviour or physical condition recorded.
Once a week, special attention was given to
the skin, and a count and classification made
of any tumours present; the exact site and
date of appearance were noted on the mouse
record card. Papillomas, including suspected
sebaceous adenomas, wererecorded when they
appeared to be greater than 1 mm3 in size,
and they had been present for at least 2
consecutive weeks. Papillomas were classi-
fied as suspected carcinomas when there was
a swelling of the dermis beneath the papil-
loma or the papilloma became "fixed"
suggesting a (tumorous) connection between
the skin and underlying muscle; or when the
papilloma had sloughed at the centre to give
rise to an ulcerated crater with rolled edges.
Regression was recorded when a papilloma
which had been present for more than 2
weeks completely disappeared. These ob-
servations were made on all animals in the
experiment.
Pathology.-A full post-mortem exami-
nation was made on all animals. Any mouse
which became moribund or distressed due to
disease (including tumour) during the course
of the experiment was killed and examined.
Those mice which died spontaneously were
examined as soon as possible, and always
within 24 h of death. Where severe auto-
lysis had occurred, only skin and macro-
scopically abnormal tissues were fixed for
histopathological examination. Rarely, all
tissues were lost because of complete canni-
balism (0.5% of all deaths).
The skin histopathological examination is
reported for the control animals and all
treated with condensates. Histopathology of
all other tissues taken was done on all the
animals in the control group, on 100 animals
chosen by random selection from groups
which contained 250 animals, and on all
animals from other groups, provided the
tissues were not autolysed or cannibalized.
The total number of animals eventually
studied was 4,052 out of the possible 4,080.
During the course of a post-mortem
examination, sections of the following tissues
were preserved in formol-corrosive for histo-
pathological examination: adrenal, caecum,
colon, duodenum, heart, ileum, jejunum,
kidney, liver, lungs, (having first beeninflated
withformolsaline), ovary, pancreas, pituitary,
salivary gland, spleen, stomach, thymus
(where it had not involuted), thyroid, urinary
bladder, uterus, voluntary muscle and any
abnormal tissue. The brain was included in
the case of suspected tumours, or where
abnormal behaviourhad beenobserved before
death. Sectionswerecutat5,um, stainedwith
haematoxylin and eosin, and special stains
where appropriate. Lymph nodes (abdomi-
nal, axillary, cervical, inguinal, mesenteric,
renal and thymic) were examined during the
course of the post-mortem examination, but
not preserved unless apparently abnormal.
Sections of skin including some normal
tissue, and all tumours inside or outside the
treated area, were preserved in Bouin's
fixative for histopathological examination.
To minimize operator bias in these and
post-mortem procedures, the training of all
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experimental assistants was managed by one
person, and each assistant at different times
was involved in all the procedures, and with
each group of animals.
Histopathology of skin on all animals in
the experiment was classified as follows:
0 Normal skin.
1 Tumours which would not normally be
classified as skin tumours, e.g. mast cell
tumours and secondary lymphoma.
2 Hyperkeratosis and hyperplasia.
3 Papilloma and other benign tumours of
epithelial origin, including sebaceous
adenoma.
4 Carcinoma I (in situ) or tumour in
which there is no evidence of infiltra-
tion but some cells show changes
characteristic of malignancy.
5 Carcinoma II: infiltrating dermis but
not into muscle.
6 Carcinoma III: a tumour infiltrating
muscle.
7 Benign tumours of connective tissue.
8 Sarcoma: malignant tumours of con-
nective tissue.
An analysis of the incidence of hyper-
plasia was based on the following criteria:
Normal: up to 3 lavers of nucleated cells
in the epithelium.
Moderate hyperplasia: 3-4 layers of
nucleated cells.
Severehyperplasia: > 4layersofnucleated
cells.
The slides were examined by a group of 6
pathologists, and the diagnoses coded for
computer storage. The pathologists agreed
the terminology to be used, but there was no
attempt to standardize the individual diag-
noses. Theslides were allocatedtoindividual
pathologists by a random selection procedure
which ensured that each of them received
material from micein allexperimental groups.
Skin-tumour incidence was subjected to
statistical analysis bothforalltumour-bearing
animals, and for animals with proven car-
cinomas. Analyses were of 2 types: the
classical age-standardizationtechnique, which
gives apercentage tuinourincidence corrected
for varying mortality patterns (Yule, 1934;
Pike, 1966; Peto and Lee, 1973) and a
mathematical modellingtechnique basedupon
the Weibull distribution (Pike, 1966; Peto
and Lee, 1973). This technique gives a
parameter b which measures the intensity
of the tumour-producing response to treat-
ment; b contains a scaling factor which is
different for the "all tumour " and " con-
fined carcinomas analysis, but within
either analysis the b values give reliable
comparisons of treatment effects. The scal-
ing factor is due to measurement of " age to
tumour " in weeks. An average of " age to
tumour " is raised to the power of 3.5 for all
tumours and 10 for carcinomas, giving scaling
factors of 107 and 1023 respectively.
The b factors calculated were almost
proportional to the corresponding stand-
ardized rates, and interpretation ofactivityis
virtually the same for both criteria.
RESULTS
Clinical observations
Evidence of nicotine poisoning (tre-
mors, and clonic contractions on external
stimulus, followed by a period of subdued
behaviour) was observed in the majority
ofmice receivingthehigh doses from 100%
tobacco or 80% tobacco/20% NSM mix-
ture during the first few weeks of the
experiment. This resulted in the death
of 8 mice receiving the high-dose conden-
sate from size A plain tobacco cigarettes.
The symptoms of nicotine poisoning
occurred within 10 min of dosing, and
lasted for several hours. By Week 8 the
evidence of nicotine poisoning was mini-
mal; animals had become acclimatized to
their respective treatments.
Also during the first 8 weeks, some
matting of the fur occurred, especially on
100% tobacco and 80% tobacco/20%
NSM mixture; this caused irritation, and
increased scratching of the painted area
occurred.
An outbreak of Tyzzer's disease occur-
red between 34 and 49 weeks (depending
on the staggered start). A totalof488 mice
wasautopsied over aperiodof6weeksand,
of these, 128 showed typical Tyzzer's
lesions of the liver. To prevent the out-
break reaching epidemic proportions and
the potential loss of the experiment, all
mice were treated with oxytetracycline
(25 mg/kg, " Imperacin ") in the drinking
water for 5 days. Oxytetracycline has
previously been found to be effective in
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TABLE III.-Percentage of Mice Bearing Skin Tumours
Observed
FAS dose (mg/
Group
100% Tob B plain
B filter
A plain
A filter
Mean
Av. cigs smoked*
80% Tob/ B plain
20% NSM B filter
A plain
A filter
Mean
Av. cigs smoked*
55%Tob/ B plain
45% NSM B filter
A plain
A filter
Mean
Av. cigs smoked*
100% NSM B plain
B filter
A plain
A filter
Mean
Av. cigs smoked*
75
10-8
10-0
7-6
8-8
9-3
2-8
10-4
10-0
8-4
7 -2
9-0
3-0
6-3
10-1
10-0
1 -3
6-9
3-7
126
27 -2
20-9
18-4
14-9
20-35
4-7
24-8
15-3
11 -6
16-8
17-1
5-0
16-3
13-8
19-0
8-8
14-5
6-2
2-0
4-0
4-0
2-0
3-0
20-0
210
44-0
44-4
36-7
38-8
41-0
7-8
44-8
33-7
36-4
36-8
37 -9
8-0
40-0
32-5
27 -5
22-5
30-6
10-3
6-0
6-0
8-0
4-0
6-0
33 -4
Age-standardized (Yule)
/wk) FAS dose (mg/wk)
, A
300 Mean 75 126 210 300 Mean
6-6 21-8 49-0
23-54 6-6 15-7 51-7 22-13 4-8 13-3 36-1
7-1 11-3 41-5
6-3 15-5 44-6
2-8 4-6 7-7
6-6
21-35 6-9
5-4
6-4
18-2
12 -5
9-3
13 -4
13-4
47-6
33-3
37-8
37 -4
39-0
19-58
3-0 5-0 8-0
4-8
17-34 6-7
0-8
4-3
3-7
13 -3
13 -3
10-3
6-7
10-9
47-7
6-63
11 -3
10-2
16-7
7-1
11 -3
6-2
1 -6
2-3
2-7
0-9
39-4
24-8
20-4
20-2
26-2
10-3
4-5 13-0
3-1 9-1
6-2 11-2
3-0 3-9
13-95
5-13
1-9 4-2 9-3
20-0 33-4 47-7
All control values are zero.
* Average cigarettes smoked: number of cigarettes
the control of Tyzzer's disease (Hunter,
1971). Ithas been suggested that Tyzzer's
disease isendemicin certain strains ofmice
(Saunders, 1958), but an outbreak only
occurs when the mice are subjected to a
stress factor. No correlation could be
found between this episode and the
subsequent tumour response. A second
minor outbreak occurred between weeks
60 and 75, and again the infection was
controlled by treatment with oxytetra-
cycline.
The overall skin-tumour response
(Table III) shows that there is a reduction
of tumour response when the proportion
of NSM present is increased, and that
there is a well-defined dose-response
relationship, the tumour yield increasing
with dosage of condensate. There is no
departure from these relationships when
any of the variables are considered on the
basis of log dose-log response effect, and
to produce the indicated mean FAS condensate dose.
it is therefore legitimate to treat the
groups as replicates when studying the
4 cigarette types.
NSM condensate produced about 25%
of the total number of skin tumours pro-
duced by a similar dose of tobacco con-
densate. It caused less than 5% of the
equivalent total of malignant tumours
(Table IV). Significant reductions of
activity per unit dose of condensate were
also observed with the blends (80/20,
P < 0-05; 55/45, P < 0-001). In terms
of dose required to produce the same
tumour response, NSM showed 31% ofthe
total tumour generation of tobacco (i.e.,
31 parts of tobacco is equivalent to 100
parts NSM), and about 22% of the
malignant tumour activity (37% and 30%
respectively at the upper confidence limits
of 95%). The 80/20 blend showed 94%
and 97% activity respectively on this
basis, and the 55/45 blend 79% and 75%.
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TABLE IV.-Percentage Mice Bearing Confirmed Carcinomas
Group
100% Tob B plain
B filter
A plain
A filter
Mean
80% Tob/ B plain
20% NSM B filter
A plain
A filter
Mean
55% Tob/ B plain
45% NSM B filter
A plain
A filter
Mean
100% NSM B plain
B filter
A plain
A filter
Mean
Observed
FAS dose (mg/wk)
75 126 210 300
8-4
7 -6
6-8
5-2
7 0
7-6
2 0
5-6
6-4
5-4
2 -5
3-8
3 -8
2 -5
3*2
0
0
0
0
0
24-8
21 -2
18-7
18 -4
20-8
26 0
16-1
19-2
15 -2
19-1
13-8
12 -5
10-0
8-8
11 -3
0
0
0
2-0
0-5
0
0
3 -4
0
0-9
Mean
9-86
(
8-81
5-12 1
0 45
0*45
Age standardized (Yule)
FAS dose (mg/wk)
75 126 210 300 Mea
1-3 4-6 20-3
0 7 3-9 15-7 6 7
0-8 3-5 11-7
0-8 2-9 14-4
0)9 3*7 15-7
1-8 3-5 19-8
0 9 1-5 12-1
16 3-7 158 6-4
0-6 3-8 12-0
1-2 3.1 14 9
1-2 1 9 7-8
0 2-8 6-5 3
0-8 2-9 5-4
0 1.5 6-2
0 5 2 3 6-5
0 0 0
0 0 0 O.C
0 0 2 6
0 1-1 0
0 0 3 0 7
an
77
O
31
All control values are zero.
TABLE V.-Weibull
All tumours*
FAS dose (mg/wk)
Group
100% Tob B plain
B filter
A plain
A filter
Mean
80% Tob/ B plain
20% NSM B filter
A plain
A filter
Mean
80% Tob/ B plain
20% NSM B filter
A plain
A filter
Mean
100% NSM B plain
B filter
A plain
A filter
Mean
75
1 82
1 65
1 25
1 75
1 *62
1 -72
1 67
1 66
1 39
1 61
1 16
1 44
1 41
0 23
1 06
126
5 49
3-84
3 -42
2-77
3-88
4-53
3-09
2 -32
3-34
3-32
2-86
2 -62
4-25
1 -75
2-87
0-31
0-71
0-72
0-38
0-53
210
12 -35
13 -05
9-07
10-72
11 -30
12-11
8-46
9-09
9-40
9-81
9-61
6 -45
5-14
5-03
6-56
1 -14
0-90
1 -57
0-85
1 -11
300
3 -45
2-66
2-32
1 -28
2 -43
b Constant4t
Confirmed carcinomast
FAS dose (mg/wk)
Mean 75 126 210 300 Mean
2-45 7-21 31-62
5-9 1-00 6-19 25-43106
1 20 5-86 18-17 1060
1-24 4-51 22-37
1-47 5-94 24-40
2-14 6-0 29-28
4-91 1-21 2-18 19-04 9-83 2-55 8-96 24-28
0-80 5-60 18-80
1-68 4.93 22-88
2-37 1-91 13-40
3-0 0 4-22 9-92 49 3 50 0-95 4-58 8 80 4-91
0 2-46 10-30
0-83 3-29 10-61
0 0 0
1-40 0 0 0 06
0 0 4.94 061
0 2-42 0
0 0-60 1-24
No malignant tumours occurred in control animals.
* Values given are b x 107.
t Values given are b x 1023.
t Weibull distribution model of the incidence of tumours over the life-time of mice is proportion of
tumour-bearing animals = exp (b(t-w)k), where t = time at which the proportion of tumour-bearing mice
is calculated.
Analysis indicated the common use of the following for each of the above 16 groups
All tumours Confirmed carcinomas
Weibull constantw 8-935 -34-615
Weibull constant k 3 094 10-0
3 -2
1-2
1 -6
1 -2
1 8
2 -8
1 -6
2-4
0-8
1 9
2 -5
0
1 -3
0
0.95
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100% NSM produced more skin tum-
ours than the solvent controls (which gave
no skin tumours at all) but gave very
significantly fewer skin tumours than any
of the other condensate treatments. The
low incidence (0 45%0) of confirmed car-
cinomas is not significantly different from
the control value.
The Weibull analyses confirm these
findings (Table V). It should be noted
that the b factors are different for
" all tumours " or " carcinomas " analyses
because of differences in the latent
periods; but within each analysis the b
values give reliable comparisons and are
closely similar to the age-standardized
rates.
Analysis of epidermal hyperplasia in
the absence of tumour pathology (Table
VI) shows that hyperplasia is virtually
only seen when tobacco is present in the
blend used to produce the condensate.
NSM condensate does not result in
significant hyperplasia. Given the re-
duced condensate yield from NSM, the
hyperplasia resulting from treatment with
condensate from blends is almost propor-
tionate to that fraction of the condensate
coming from tobacco.
General pathological examination of
tissues other than skin revealed an
extensive range of neoplastic and other
pathology (Tables VII and VIII). The
TABLE VI.-Percentage Tumour-free Mice
with Moderate or Severe Hyperplasia
Treatment
100% Tob
8000 Tob/2000 NSM
550O Tob/4500 NSM
100% NSM
Control
Dose (mg/wk)
11A
75 126 210 300
23-5 43 5 51-5
18-5 34-5 44 0
19-0 27-0 41-0
3 0 4 0 7 0
3 0
percentage oftumours observed (Table IX)
is constant in all groups. About 25% of
these are lymphomas. There is no indica-
tionofa specific lesionattributable totreat-
ment, nor is there evidence of a difference
between condensates derived from filtered
or plain cigarettes.
DISCUSSION
It has been claimed that the carcino-
genic properties of tobacco smoke reside
almost wholly in the particulate phase of
the smoke (Wynder and Hoffmann, 1968).
Although this view has been questioned
(Leuchtenberger et al., 1967; Braven et al.,
1967; Leuchtenberger and Leuchtenberger
1969), it is likely that the particulate phase
contains a significant proportion of the
active chemicals (Van Duuren, 1968). NSM
is chemically simpler than tobacco as a
result of the smaller proportion of organic
material present, and the condensate from
NSM is likewise less complex than that
from tobacco. It was predictable, there-
fore, that NSM condensate would be less
active than tobacco condensate. The
main object ofthis work was to determine
the tumour-producing activity of NSM
smoke condensate when applied to mouse
skin, and to compare this, at different
applied dosages, with condensate from a
typical flue-cured tobacco and from blends
of flue-cured tobacco with NSM. In
addition, it was intended to measure any
interaction between NSM and tobacco
which resulted in enhanced activity.
Finally, it was thought that more general
pathology might result, either from con-
densate absorption through the skin, or by
ingestion of applied condensate following
natural animal grooming.
The results of these experiments have
shown that NSM condensate has less than
37%o of the overall activity of tobacco
condensate. The material produced very
few carcinomas in different groups, so that
these results are insufficiently precise, but
this incidence does not differ significantly
from the controls, and is certainly less
than 30%0 the activity of tobacco.
Apart from the true reduction of
tumour-producing activity, the observed
effects could be due to other substances in
the NSM condensate which either interfere
with its activity, or reduce the extent of
skin contact. Substantial amounts of
glycerol are present, for example, and
this might inhibit absorption of the
carcinogenic constituents. Specific experi-
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TABLE IX.-The Overall Incidence ofTumours and Lymphomas, ExcludingSkin Tumours
Dosage
I~ I
75 126 210 300
A1 ,A ) - - A r
Other Other Other Other
Lymphoma tumours Lymphoma tumours Lymphoma tumours Lymphoma tumours
23 60-5 20 55 19 57
21 62 22 58 17 53
25 63 20 60
24-5 64-5
22 66 - 5
21 63-5 14 48
Lymphomas 24
Other tumours 58
ments to test this possibility (to be
published) show little or no significant
effect ofglycerol on skin-tumour incidence
in mice when it is added to tobacco con-
densates before skin application.
Similarly, it is known that acetone can
react with glycerol, in the presence ofacid,
to form solketal (isopropylidene glycerol-
Renoll and Newman, 1968). If this
occurred to any great extent, the conden-
sate doses would be incorrectly calculated,
and again there could be some interference
with the interaction between the carcino-
genic moiety and the mouse skin. Analy-
sis has shown that less than 1.5% solketal
was formed in the condensates used in this
experiment, and that, even under the most
favourable conditions, only 3% was formed
after 7 weeks' storage. Such small
amounts could not result in the marked
reduction of activity found in this study.
The possibility of phase separation of
condensate before application, to which
substitute condensates are sometimes
prone, was avoided in this experiment by
shaking the solution before application.
Without this, it is obviously possible to
apply different phases which might possess
different activities (Chortyk and Bock,
1976).
The small yield of NSM condensate
results in a blend condensate which is
preponderantly of tobacco origin. The
yield of condensate from an 80% tobacco
blend is theoretically 85% that of a normal
cigarette, but of this condensate 94%
could be attributable to tobacco. Even
at 55% tobacco, 83% ofthe content ofthe
much-reduced blend condensate is derived
from tobacco. It was this relatively
minor variation in the effective tobacco
contribution in the various blend conden-
sates which made necessary the very large
numbers of mice in the trial, if valid
statistical conclusions were to be drawn.
A major source of concern was the
possibility that any reduction in activity
achieved by adding NSM to a blend could
be offset by an adverse interaction caused
by the conjoint burning of NSM and
tobacco. No such interaction is demon-
strated.
In addition, these minor changes could
be influenced in a major way by slight
variation in condensate yields during the
smoking ofthe different cigarette types. It
is probably more realistic to compare the
relative activities of the different blends
on the basis of the cigarettes smoked to
produce the doses of condensate. This
has the added advantage of giving the
combined effect of reduced condensate
and reduced condensate activity.
Thus it may be calculated that a com-
bination of filter and 20% NSM results in
about 33% less of fresh anhydrous
smoke condensate per cigarette, than
with the unfiltered 100% tobacco
cigarette (Table I), and that the conden-
sate itself shows less tumour-producing
activity than that derived from tobacco
(Table V). The combined effect could
result in a cigarette which shows over 40%
less activity than the unfiltered tobacco
Treatment
100% Tob.
80% Tob./
20% NSM
55% Tob./
45%O NSM
100% NSM
Control
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TABLE X.-Comparisons of the Effect of NSM and Filters on the FAS
Condensate Yield and Skin Tumour Effects (%)
Cigarette
type Treatment
100% Tob.
B plain 80% Tob./20% NSM
55% Tob./45% NSM
100%o Tob.
B filter 80% Tob./20% NSM
55% Tob./45% NSM
100% Tob.
A plaiin 80% Tob/.20% NSM
55% Tob./45% NSM
100% Tob.
A filter 80% Tob./20% NSM
55% Tob./450, NSM
Overall
tumour
rate
25-8
24-1
18 -5
24-6
17 -6
13-3
18-1
17 -9
14-6
20 0
18-7
9 -4
Relative*
activity of
condensate
100
95.5
81-2
95 2
80 3
71-8
82-1
79-6
71-5
88-2
85-6
63 -3
Number of B plain
100% Tob. cigarettes
equivalent to 100
test cigarettes
100
85-7
59-1
71-2
56-0
43 -2
73-9
71*9
51-2
55.9
49 7
29-1
* Derived from regression analyses on values of Weilbull b.
cigarette (Table X). These figures relate
to the control tobacco used in these
experiments, which yields greater amounts
of condensate than are commonly pro-
duced from the commercial blends of
today. Similar calculations for different
types (Table X) show the relative effects
of combining filter and substitute.
Skin hyperplasia (in the absence of
other skin tumours) was closely linked to
the amount oftobacco condensate painted
on the mouse, showing a strong dose-
response relationship. There were indi-
cations that, as the proportion of NSM
increased in the blend, there was a slight
reduction of hyperplasia; 100% NSM
condensate producing virtually no hyper-
plasia. These results would suggest that
NSM makes little qualitative contribution
to those factors responsible for hyper-
plasia.
There was a possibility that a propor-
tionoftheappliedcondensatewasabsorbed
through the skin or ingested while groom-
ing, and that this might lead to systemic
pathology. The absence of any systemic
pathologyrelatedto aparticulartreatment
shows that there is no constituent of the
condensate which is likely to result in
marked and unsuspected pathology, if
absorption occurs.
The relevance ofthe mouse skin model
to human carcinogenesis remains un-
certain. If it is regarded as a model
system to determine the comparative
effects ofsmoke condensates on a tissue in
terms of neoplastic response, then the
present work indicates that NSM conden-
sate is significantly less carcinogenic than
tobacco condensate, and offers a method
compatible with others to reduce the
potential hazards of cigarette smoking.
The incorporation ofNSM into tobacco
cigarettes wouldhave aneffect comparable
to a reduction in the number of tobacco
cigarettes smoked. If there is a linear
relationship between numbers smoked and
lung cancer (DollandPike, 1972) andifthe
mouse skin model applies, then the
expected reductions in lung cancer inci-
dences would approximate the amount of
NSM present. Confirmation of this will
require prolonged inhalation studies in
experimental animals capable of respond-
ing to inhaled smoke by the development
ofbronchopulmonary tumours, or by pro-
longedexposure in manwiththe attendant
epidemiological studies. In the absence
of precise understanding of the carcino-
genic mechanisms operating in mouse skin,
however, it still has validity only as a
model for comparing the relative potencies
of topically applied materials.
It is worth noting that the relevance
of these comments would be severely
reduced ifthe activity ofNSM condensate
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was not less than that of the control
material derived from tobacco. If this
was not so, it would be difficult to predict
with confidence a beneficial effect to the
human smoker, even if the amount of
condensate was reduced. Given the vari-
ability of dosage which actually occurs
over the long periods of exposure of the
human smoker, due for example to depth
of inhalation or rate of smoking, mere
reduction of condensate yield might be
more than offset by increased potency, or
the increased sensitivity of the human
bronchus compared with mouse skin.
The safest course must be to reduce both
the amount and activity of the tar.
We acknowledge with gratitude the
invaluable help provided by Mr J. V.
Gregg and Mr W. S. Paige in the experi-
mental design and statistical analyses.
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